The story of Viagra, and its parent company copyright, presents a complex case study for investors. Initially a blockbuster drug, yielding billions in revenue , its exclusivity period created a deluge of knock-off medications, significantly impacting its position . While specific pharmaceutical companies may try to capitalize on male sexual dysfunc